Azathioprine treatment during lactation

Alimentary Pharmacology and Therapeutics

Volumn 28, Issue 10, 2008, Pages 1209-1213

  Christensen, L A ^a   Dahlerup, J F ^a   Nielsen, M J ^a   Fallingborg, J F ^b   Schmiegelow, K ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; MESALAZINE; PREDNISOLONE;

ADULT; ARTICLE; BREAST FEEDING; BREAST MILK; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DRUG BIOAVAILABILITY; DRUG METABOLISM; ENTERITIS; FEMALE; GENE MUTATION; HUMAN; LACTATION; PHENOTYPE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; AZATHIOPRINE; BREAST FEEDING; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; LACTATION; MILK, HUMAN; PREGNANCY;

EID: 54049083794     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03843.x     Document Type: Article

References (20)

1. Roblin X, Serre-Debeauvais F, Phelip JM, et al. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine. Aliment Pharmacol Ther 2005 21: 829 39.
2. Caprilli R, Gassull MA, Escher JC, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006 55 (Suppl. 1 i36 58.
3. Lichtenstein GR, Sbreu MT, Cohen R, Tremaine W. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Rev Gastroenterol Mex 2006 71: 351 401.
4. Gardiner SJ, Gearry RB, Roberts RL, Zhang M, Barclay ML, Begg EJ. Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. Br J Clin Pharmacol 2006 62: 453 6.
5. Gardiner SJ, Begg EJ, Sau A, Marinaki A, Gearry RB, Barclay ML. Thiopurine treatment in inflammatory bowel disease. Clin Pharmacokinet 2007 46: 803 4.
6. Teml A, Schaeffeler E, Herrlinger KR, Klotz U, Schwab M. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. Clin Pharmacokinet 2007 46: 187 208.
7. Schwab M, Klotz U. Pharmacokinetic considerations in the treatment of inflammatory bowel disease. Clin Pharmacokinet 2001 40: 723 51.
8. Hindorf U, Lyrenas E, Nilsson A, Schmiegelow K. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease. Scand J Gastroenterol 2004 39: 1105 12.
9. Coulam CB, Moyer TP, Jiang NS, Zincke H. Breast-feeding after renal transplantation. Transplant Proc 1982 14: 605 9.
10. Sau A, Clarke S, Bass J, Kaiser A, Marinaki A, Nelson-Piercy C. Azathioprine and breastfeeding: is it safe? BJOG 2007 114: 498 501.
11. Bruunshuus I, Schmiegelow K. Analysis of 6-mercaptopurine, 6-thioguanine nucleotides, and 6-thiouric acid in biological fluids by high-performance liquid chromatography. Scand J Clin Lab Invest 1989 49: 779 84.
12. Erdmann GR, France LA, Bostrom BC, Canafax DM. A reversed phase high performance liquid chromatography approach in determining total red blood cell concentrations of 6-thioguanine, 6-mercaptopurine, methylthioguanine, and methylmercaptopurine in a patient receiving thiopurine therapy. Biomed Chromatogr 1990 4: 47 51.
13. Weinshilboum RM, Raymond FA, Pazmino PA. Human erythrocyte thiopurine methyltransferase: Radiochemical microassay and biochemical properties. Clin Chim Acta 1978 85: 323 33.
14. Wilson JT. Determinants and consequences of drug excretion in breast milk. Drug Metab Rev 1983 14: 619 52.
15. Wilson JT, Brown RD, Hinson JL, Dailey JW. Pharmacokinetic pitfalls in the estimation of the breast milk/plasma ratio for drugs. Annu Rev Pharmacol Toxicol 1985 25: 667 89.
16. Ding TL, Benet LZ. Determination of 6-mercaptopurine and azathioprine in plasma by high-performance liquid chromatography. J Chromatogr 1979 163: 281 8.
17. Derijks LJ, Hommes DW. Thiopurines in inflammatory bowel disease: new strategies for optimization of pharmacotherapy? Curr Gastroenterol Rep 2006 8: 89 92.
18. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980 32: 651 62.
19. Gilissen LP, Derijks LJ, Bos LP, et al. Some cases demonstrating the clinical usefulness of therapeutic drug monitoring in thiopurine-treated inflammatory bowel disease patients. Eur J Gastroenterol Hepatol 2004 16: 705 10.
20. Stevens T, Achkar JP, Easley K, Brzezinski A, Lashner B. Azathioprine formulation optimizes metabolite profile in inflammatory bowel disease. Aliment Pharmacol Ther 2004 20: 601 6.